AllianceBernstein’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $330M | Sell |
426,914
-51,475
| -11% | -$39.4M | 0.11% | 153 |
|
|
2025
Q4 | $369M | Sell |
478,389
-45,494
| -9% | -$30.9M | 0.12% | 138 |
|
|
2025
Q3 | $295M | Sell |
523,883
-63,344
| -11% | -$35.8M | 0.09% | 170 |
|
|
2025
Q2 | $308M | Sell |
587,227
-22,381
| -4% | -$12.5M | 0.1% | 165 |
|
|
2025
Q1 | $387M | Sell |
609,608
-13,548
| -2% | -$9.32M | 0.14% | 126 |
|
|
2024
Q4 | $444M | Buy |
623,156
+43,638
| +8% | +$36.6M | 0.15% | 114 |
|
|
2024
Q3 | $609M | Sell |
579,518
-115,579
| -17% | -$129M | 0.2% | 88 |
|
|
2024
Q2 | $731M | Sell |
695,097
-41,436
| -6% | -$40.2M | 0.25% | 75 |
|
|
2024
Q1 | $709M | Sell |
736,533
-7,684
| -1% | -$7.31M | 0.25% | 79 |
|
|
2023
Q4 | $654M | Buy |
744,217
+51,959
| +8% | +$42.8M | 0.25% | 82 |
|
|
2023
Q3 | $570M | Buy |
692,258
+4,399
| +0.6% | +$3.46M | 0.24% | 83 |
|
|
2023
Q2 | $494M | Buy |
687,859
+74,973
| +12% | +$57.8M | 0.2% | 99 |
|
|
2023
Q1 | $504M | Buy |
612,886
+7,708
| +1% | +$5.81M | 0.22% | 103 |
|
|
2022
Q4 | $437M | Sell |
605,178
-48,195
| -7% | -$35.6M | 0.2% | 112 |
|
|
2022
Q3 | $450M | Sell |
653,373
-672
| -0.1% | -$423K | 0.22% | 101 |
|
|
2022
Q2 | $387M | Buy |
654,045
+76,176
| +13% | +$49.5M | 0.18% | 119 |
|
|
2022
Q1 | $404M | Buy |
577,869
+7,749
| +1% | +$4.9M | 0.16% | 127 |
|
|
2021
Q4 | $360M | Buy |
570,120
+68,434
| +14% | +$42.1M | 0.13% | 157 |
|
|
2021
Q3 | $304M | Sell |
501,686
-378,465
| -43% | -$235M | 0.12% | 161 |
|
|
2021
Q2 | $492M | Sell |
880,151
-1,197,100
| -58% | -$606M | 0.2% | 99 |
|
|
2021
Q1 | $983M | Buy |
2,077,251
+313,907
| +18% | +$153M | 0.43% | 44 |
|
|
2020
Q4 | $852M | Buy |
1,763,344
+208,936
| +13% | +$113M | 0.4% | 48 |
|
|
2020
Q3 | $870M | Buy |
1,554,408
+11,662
| +0.8% | +$7.07M | 0.47% | 39 |
|
|
2020
Q2 | $962M | Sell |
1,542,746
-281,790
| -15% | -$160M | 0.57% | 28 |
|
|
2020
Q1 | $891M | Sell |
1,824,536
-128,021
| -7% | -$52.8M | 0.64% | 27 |
|
|
2019
Q4 | $733M | Sell |
1,952,557
-172,219
| -8% | -$57.9M | 0.42% | 47 |
|
|
2019
Q3 | $589M | Buy |
2,124,776
+599,187
| +39% | +$177M | 0.37% | 55 |
|
|
2019
Q2 | $478M | Buy |
1,525,589
+372,238
| +32% | +$124M | 0.3% | 72 |
|
|
2019
Q1 | $474M | Sell |
1,153,351
-104,355
| -8% | -$43M | 0.31% | 68 |
|
|
2018
Q4 | $470M | Buy |
1,257,706
+234,112
| +23% | +$85.7M | 0.35% | 63 |
|
|
2018
Q3 | $414M | Buy |
1,023,594
+269,696
| +36% | +$103M | 0.27% | 80 |
|
|
2018
Q2 | $260M | Buy |
753,898
+533,434
| +242% | +$167M | 0.18% | 117 |
|
|
2018
Q1 | $75.9M | Sell |
220,464
-10,681
| -5% | -$3.71M | 0.05% | 367 |
|
|
2017
Q4 | $86.9M | Buy |
231,145
+11,324
| +5% | +$4.59M | 0.06% | 346 |
|
|
2017
Q3 | $98.3M | Sell |
219,821
-14,543
| -6% | -$6.92M | 0.07% | 289 |
|
|
2017
Q2 | $115M | Buy |
234,364
+413
| +0.2% | +$181K | 0.09% | 239 |
|
|
2017
Q1 | $90.7M | Buy |
233,951
+9,759
| +4% | +$3.62M | 0.07% | 302 |
|
|
2016
Q4 | $82.3M | Sell |
224,192
-17,963
| -7% | -$6.83M | 0.07% | 314 |
|
|
2016
Q3 | $97.4M | Sell |
242,155
-2,829
| -1% | -$1.13M | 0.08% | 250 |
|
|
2016
Q2 | $85.6M | Sell |
244,984
-1,779
| -0.7% | -$685K | 0.07% | 280 |
|
|
2016
Q1 | $88.9M | Buy |
246,763
+52,033
| +27% | +$21.4M | 0.08% | 280 |
|
|
2015
Q4 | $106M | Buy |
194,730
+44,646
| +30% | +$24.2M | 0.09% | 242 |
|
|
2015
Q3 | $69.8M | Buy |
150,084
+1,124
| +0.8% | +$604K | 0.06% | 347 |
|
|
2015
Q2 | $76M | Buy |
148,960
+1,486
| +1% | +$725K | 0.06% | 344 |
|
|
2015
Q1 | $66.6M | Sell |
147,474
-2,350
| -2% | -$996K | 0.05% | 388 |
|
|
2014
Q4 | $61.5M | Buy |
149,824
+95
| +0.1% | +$37.4K | 0.05% | 402 |
|
|
2014
Q3 | $54M | Sell |
149,729
-5,262
| -3% | -$1.76M | 0.05% | 432 |
|
|
2014
Q2 | $43.8M | Sell |
154,991
-13,074
| -8% | -$3.87M | 0.04% | 502 |
|
|
2014
Q1 | $50.5M | Buy |
168,065
+2,788
| +2% | +$859K | 0.04% | 457 |
|
|
2013
Q4 | $45.5M | Buy |
165,277
+897
| +0.5% | +$258K | 0.04% | 472 |
|
|
2013
Q3 | $51.4M | Sell |
164,380
-1,178
| -0.7% | -$310K | 0.05% | 419 |
|
|
2013
Q2 | $37.2M | Buy |
+165,558
| New | +$38.6M | 0.04% | 476 |
|
Other funds holding REGN
VCM
N
AllianceBernstein's REGN Position: Q1 2026 in Review
AllianceBernstein reduced its Regeneron Pharmaceuticals (REGN) stake by 11% in Q1 2026, selling an estimated $39.4M and leaving 426,914 shares worth $330M. The position accounts for 0.11% of the portfolio, ranked #153.
AllianceBernstein first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $983M in Q1 2021. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- AllianceBernstein held 426,914 shares of Regeneron Pharmaceuticals worth $330M as of Q1 2026.
- AllianceBernstein sold 51,475 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $39.4M.
- Regeneron Pharmaceuticals made up 0.11% of AllianceBernstein's portfolio in Q1 2026, its #153 holding.
- AllianceBernstein first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Regeneron Pharmaceuticals position peaked at $983M in Q1 2021.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.